R&D | February 04, 2026
Epigenica launches EpiFinder Analysis Service to accelerate Epigenomic research
The new service delivers end-to-end support, managing every stage of an epigenomics project
The new service delivers end-to-end support, managing every stage of an epigenomics project
The approval expands the drug’s existing COPD indication, making it the only single-inhaler triple therapy (SITT) available for both respiratory conditions in China
VETMEDIN (pimobendan) chewable tablets and VETMEDIN solution (pimobendan oral solution) can delay the onset of congestive heart failure (CHF) in dogs
The registrations grant Neurizon exclusive rights to use and defend its brand across its core operating regions
Treatment typically requires frequent injections directly into the eye—an ongoing burden for patients and health systems alike
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
Experts caution that realizing AI’s potential requires careful management and risk mitigation
Backed by two CAP - accredited genomics labs in Delhi NCR and Mumbai, supporting oncology, reproductive health, neurology, transplant immunology, and rare diseases
The integration unifies brand and field strategy, drives executional alignment, and delivers immediate impact measurement
Nxera will take full responsibility for regulatory approvals, clinical development where required, manufacturing and commercialization in the licensed territories
Subscribe To Our Newsletter & Stay Updated
